Grifols
Global plasma-derived medicines group that fractionates human plasma into immunoglobulins, albumin and coagulation therapies, and also supplies diagnostics and hospital products. It operates a large plasma-collection network across the United States, Europe and Canada.
Company Info
Sector:Plasma-Derived Therapeutics
Headquarters:Barcelona, Spain
Founded:1940
Website:www.grifols.com/en/home
Clinical Development Pipeline
Gamunex-C
Target: Polyclonal human IgGProlastin-C
Target: Alpha-1 proteinase inhibitorXembify
Target: 20% subcutaneous human IgGRecent News
No recent news updates available for this company.
Leadership Team
Jose Ignacio (Nacho) Abia
Chief Executive Officer (since April 2024)
Thomas Glanzmann
Executive Chairman